The potential to treat and protect, improve outcomes and provide hope for immunocompromised patients
With a goal of supporting those who've been there all along
Working to potentially expand treatment options for healthcare professionals
Together we aim to build a more hopeful future for immunocompromised patients
At Chimerix, we’re committed to driving the development of groundbreaking medicines designed to protect immunocompromised patients from potentially deadly viral infections.
Adenovirus, which causes the common cold in people with healthy immune systems, can lead to life-threatening infections in immunocompromised people.4
Cytomegalovirus (CMV) is a member of the herpesvirus family and remains a significant cause of viral infections in transplant recipients.
The majority of adults have been infected with BK virus6, which can reactivate and cause severe complications in stem cell transplant and solid organ transplant recipients, and other immunocompromised individuals. 7
Though smallpox has been officially eradicated, it remains a threat in cases of bioterror or as a potential bioterror weapon.
Noroviruses are the most common cause of acute gastroenteritis worldwide. In immunocompromised adults, norovirus infection can become chronic and persist for weeks to years.8